Dr. Hosam Farouk El Sayed, MD

Dr. El Sayed practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Dr. El Sayed's NPI, 1063598977, was assigned on October 31, 2006. Dr. El Sayed graduated from Cairo University School of Medicine in 1990. Dr. El Sayed holds Virginia license 0101266758.

Dr. El Sayed's primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Dr. El Sayed's primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. Dr. El Sayed is also affiliated with Sentara Leigh Hospital. The medical group on file is Sentara Medical Group. Dmand AI also links Dr. El Sayed to 3 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El Sayed practices, 8 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. El Sayed's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. El Sayed is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. El Sayed's licenses on file in 3 states: Virginia, Ohio and Texas.

Dmand AI lists carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. El Sayed treats.

CMS data shows 4,470 Medicare services from Dr. El Sayed across 28 procedure codes in 2024, for 3,460 Medicare patients. Medicare paid $146,051 for them.

CMS counts 3,460 Medicare patients who saw Dr. El Sayed in 2024. The largest group is 75 to 84, with 1,347 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El Sayed's median patient age at 65, with 52% women.

In 2024, Dr. El Sayed wrote 84 Medicare Part D claims for 39 patients. 92% of them were for generic drugs. CMS names the drug for 47 of them, across 2 drugs with 11 or more claims each, at $354 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

Dr. El Sayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. El Sayed, published from 2007 to 2017. 2007 was the busiest year, with 2. The most frequent topics are Stents, Venous Thrombosis and Angioplasty, Balloon. Dr. El Sayed has published most often in Vascular. Dr. El Sayed's most frequent co-authors are Peter H. Lin, MD, Panagiotis Kougias, MD and Mark Glynn Davies, MD.

Dmand AI links Dr. El Sayed to 1 clinical trial.

CMS Open Payments shows 348 general payments to Dr. El Sayed from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 36% of the total. Medtronic, Inc. paid the most, $36,453.

Dmand AI lists 1 award for Dr. El Sayed, most recently CMS Stage 1 EHR in 2012.

Dr. El Sayed graduated from Cairo University School of Medicine in 1990. Dr. El Sayed is a member of European Society of Vascular Surgery-ESVS, Midwestern Vascular Society, SVS, Society of Clinical Vascular Surgery-SCVS, Society of University Surgeons-SUS and Vascular and Endovascular Surgery Society- VESS.

Dr. El Sayed is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.